Weekly Research Analysts’ Ratings Updates for Oscar Health (OSCR)

Oscar Health (NYSE: OSCR) recently received a number of ratings updates from brokerages and research firms:

• 11/25/2025 – Oscar Health was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They now have a $25.00 price target on the stock, up previously from $13.00.
• 11/22/2025 – Oscar Health was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating.
• 11/13/2025 – Oscar Health had its price target lowered by analysts at Wells Fargo & Company from $14.00 to $11.00. They now have an “underweight” rating on the stock.
• 11/10/2025 – Oscar Health had its price target raised by analysts at Barclays PLC from $11.00 to $13.00. They now have an “underweight” rating on the stock.
• 11/7/2025 – Oscar Health had its price target raised by analysts at UBS Group AG from $11.00 to $12.00. They now have a “sell” rating on the stock.
• 10/14/2025 – Oscar Health is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $17.00 price target on the stock.
• 10/14/2025 – Oscar Health is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $17.00 price target on the stock.
• 10/13/2025 – Oscar Health was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating.
• 10/8/2025 – Oscar Health had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Oscar Health had its price target raised by analysts at Wells Fargo & Company from $10.00 to $14.00. They now have an “underweight” rating on the stock.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 286,182 shares of the stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $15.27, for a total transaction of $4,369,999.14. Following the sale, the insider directly owned 501,148 shares in the company, valued at approximately $7,652,529.96. This trade represents a 36.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 24.39% of the stock is owned by company insiders.

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.